Author | Design | County | Male% | Setting | Prevalence of frailty | Sample size | Age/years | Frailty Criteria | Effect measures | Outcome assessed |
---|---|---|---|---|---|---|---|---|---|---|
Laursen 2021 [23] | RCS | Denmark | 56% | Hospital | 20% | 284 | 74(67–80) | modified Frailty index | RR | 90-day mortality |
Johnson 2021 [17] | RCS | USA | 43.5% | Hospital | 23% | 5341 | Aged> 50 years | Frailty index | HR | 1-year mortality |
Ferguson 2021 [22] | PCS | UK | 38.8% | Hospital | 37.4% | 6682 | Aged> 65 years | electronic Frailty index | RR | 90-day mortality |
Schwartz 2021 [21] | RCS | USA | 38% | Hospital | 19.8% | 179,702 | 66.4 ± 6.6 | modified Frailty index | RR | 30-day mortality |
R.L Johnson 2018 [20] | PCS | USA | 48.8% | Hospital | 22.7% | 8640 | Aged> 50 years | Frailty index | HR | 90-day mortality |
Mclsaac D. I 2016 [19] | RCS | Canada | 39% | Hospital | 2.4% | 125,163 | 74(6) | ACG | HR | 1-year mortality |
Mclsaac 2016 [18] | RCS | Canada | 44.4% | Hospital | 3.1% | 134,782 | Aged> 65 years | ACG | HR | 1-year mortality |
R.L Johnson 2021 [24] | PCS | USA | 45.8% | Hospital | NA | 18,397 | 68(61,75) | Frailty index | HR | In-hospital mortality |
Runner 2017 [25] | RCS | USA | 37.2% | Hospital | NA | 90,260 | 70.75 ± 7.17 | modified Frailty index | OR | In-hospital mortality |
Shin 2016 [26] | RCS | USA | 40.5% | Hospital | NA | 39,807 | Aged> 18 years | modified Frailty index | OR | In-hospital mortality |
Sophia 2018 [27] | RCS | USA | 55.2% | Hospital | NA | 140,158 | 64.8 | modified Frailty index | OR | In-hospital mortality |
Traven 2019 [28] | RCS | USA | 41.1% | Hospital | NA | 16,304 | 65.2 | modified Frailty index | OR | In-hospital mortality |